
TY  - JOUR
AU  - Czermak, B.J.
TI  - Protective effects of C5a blockade in sepsis
JA  - Nat. Med.
PY  - 1999///
VL  - 5
SP  - 788
EP  - 792
PB  - Nature Publishing Group
M3  - 10.1038/10512
N1  - 10.1038/10512
UR  - http://dx.doi.org/10.1038/10512
ER  -

TY  - JOUR
AU  - Gerard, N.P.
AU  - Gerard, C.
TI  - The chemotactic receptor for human C5a anaphylatoxin
JA  - Nature
PY  - 1991///
VL  - 349
SP  - 614
EP  - 617
PB  - Nature Publishing Group
M3  - 10.1038/349614a0
N1  - 10.1038/349614a0
UR  - http://dx.doi.org/10.1038/349614a0
ER  -

TY  - JOUR
AU  - Gerard, C.
AU  - Gerard, N.P.
TI  - C5A anaphylatoxin and its seven transmembrane-segment receptor
JA  - Annu. Rev. Immunol.
PY  - 1994///
VL  - 12
SP  - 775
EP  - 808
PB  - Nature Publishing Group
M3  - 10.1146/annurev.immunol.12.1.775
N1  - 10.1146/annurev.immunol.12.1.775
UR  - http://dx.doi.org/10.1146/annurev.immunol.12.1.775
ER  -

TY  - JOUR
AU  - Cain, S.A.
AU  - Monk, P.N.
TI  - The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg74
JA  - J. Biol. Chem.
PY  - 2002///
VL  - 277
SP  - 7165
EP  - 7169
PB  - Nature Publishing Group
M3  - 10.1074/jbc.C100714200
N1  - 10.1074/jbc.C100714200
UR  - http://dx.doi.org/10.1074/jbc.C100714200
ER  -

TY  - JOUR
AU  - Johswich, K.
TI  - Ligand specificity of the anaphylatoxin C5L2 receptor and its regulation on myeloid and epithelial cell lines
JA  - J. Biol. Chem.
PY  - 2006///
VL  - 281
SP  - 39088
EP  - 39095
PB  - Nature Publishing Group
M3  - 10.1074/jbc.M609734200
N1  - 10.1074/jbc.M609734200
UR  - http://dx.doi.org/10.1074/jbc.M609734200
ER  -

TY  - JOUR
AU  - Okinaga, S.
TI  - C5L2, a nonsignaling C5A binding protein
JA  - Biochemistry
PY  - 2003///
VL  - 42
SP  - 9406
EP  - 9415
PB  - Nature Publishing Group
M3  - 10.1021/bi034489v
N1  - 10.1021/bi034489v
UR  - http://dx.doi.org/10.1021/bi034489v
ER  -

TY  - JOUR
AU  - Kalant, D.
TI  - The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein
JA  - J. Biol. Chem.
PY  - 2003///
VL  - 278
SP  - 11123
EP  - 11129
PB  - Nature Publishing Group
M3  - 10.1074/jbc.M206169200
N1  - 10.1074/jbc.M206169200
UR  - http://dx.doi.org/10.1074/jbc.M206169200
ER  -

TY  - JOUR
AU  - Kalant, D.
TI  - C5L2 is a functional receptor for acylation-stimulating protein
JA  - J. Biol. Chem.
PY  - 2005///
VL  - 280
SP  - 23936
EP  - 23944
PB  - Nature Publishing Group
M3  - 10.1074/jbc.M406921200
N1  - 10.1074/jbc.M406921200
UR  - http://dx.doi.org/10.1074/jbc.M406921200
ER  -

TY  - JOUR
AU  - Kildsgaard, J.
TI  - Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock
JA  - J. Immunol.
PY  - 2000///
VL  - 165
SP  - 5406
EP  - 5409
PB  - Nature Publishing Group
ER  -

TY  - JOUR
AU  - Takabayashi, T.
TI  - A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis
JA  - J. Immunol.
PY  - 1996///
VL  - 156
SP  - 3455
EP  - 3460
PB  - Nature Publishing Group
ER  -

TY  - JOUR
AU  - Gerard, N.P.
TI  - An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2
JA  - J. Biol. Chem.
PY  - 2005///
VL  - 280
SP  - 39677
EP  - 39680
PB  - Nature Publishing Group
M3  - 10.1074/jbc.C500287200
N1  - 10.1074/jbc.C500287200
UR  - http://dx.doi.org/10.1074/jbc.C500287200
ER  -

TY  - JOUR
AU  - Johswich, K.
AU  - Klos, A.
TI  - C5L2[mdash]an anti-inflammatory molecule or a receptor for acylation stimulating protein (C3a-desArg)?
JA  - Adv. Exp. Med. Biol.
PY  - 2007///
VL  - 598
SP  - 159
EP  - 180
PB  - Nature Publishing Group
ER  -

TY  - JOUR
AU  - Chen, N.J.
TI  - C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a
JA  - Nature
PY  - 2007///
VL  - 446
SP  - 203
EP  - 207
PB  - Nature Publishing Group
M3  - 10.1038/nature05559
N1  - 10.1038/nature05559
UR  - http://dx.doi.org/10.1038/nature05559
ER  -

TY  - JOUR
AU  - Ohno, M.
TI  - A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells, but not in mature dendritic cells
JA  - Mol. Immunol.
PY  - 2000///
VL  - 37
SP  - 407
EP  - 412
PB  - Nature Publishing Group
M3  - 10.1016/S0161-5890(00)00067-5
N1  - 10.1016/S0161-5890(00)00067-5
UR  - http://dx.doi.org/10.1016/S0161-5890(00)00067-5
ER  -

TY  - JOUR
AU  - Huber-Lang, M.
TI  - Changes in the novel orphan, C5a receptor (C5L2), during experimental sepsis and sepsis in humans
JA  - J. Immunol.
PY  - 2005///
VL  - 174
SP  - 1104
EP  - 1110
PB  - Nature Publishing Group
ER  -

TY  - JOUR
AU  - Hopken, U.E.
AU  - Lu, B.
AU  - Gerard, N.P.
AU  - Gerard, C.
TI  - Impaired inflammatory responses in the reverse arthus reaction through genetic deletion of the C5a receptor
JA  - J. Exp. Med.
PY  - 1997///
VL  - 186
SP  - 749
EP  - 756
PB  - Nature Publishing Group
M3  - 10.1084/jem.186.5.749
N1  - 10.1084/jem.186.5.749
UR  - http://dx.doi.org/10.1084/jem.186.5.749
ER  -

TY  - JOUR
AU  - Otto, M.
TI  - C5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonism
JA  - J. Biol. Chem.
PY  - 2004///
VL  - 279
SP  - 142
EP  - 151
PB  - Nature Publishing Group
M3  - 10.1074/jbc.M310078200
N1  - 10.1074/jbc.M310078200
UR  - http://dx.doi.org/10.1074/jbc.M310078200
ER  -

TY  - JOUR
AU  - Gao, H.
TI  - Evidence for a functional role of the second C5a receptor C5L2
JA  - FASEB J.
PY  - 2005///
VL  - 19
SP  - 1003
EP  - 1005
PB  - Nature Publishing Group
ER  -

TY  - JOUR
AU  - Lee, H.
TI  - Human C5aR knock-in mice facilitate the production and assessment of anti-inflammatory monoclonal antibodies
JA  - Nat. Biotechnol.
PY  - 2006///
VL  - 24
SP  - 1279
EP  - 1284
PB  - Nature Publishing Group
M3  - 10.1038/nbt1248
N1  - 10.1038/nbt1248
UR  - http://dx.doi.org/10.1038/nbt1248
ER  -

TY  - JOUR
AU  - Czermak, B.J.
TI  - In vitro and in vivo dependency of chemokine generation on C5a and TNF-[alpha]
JA  - J. Immunol.
PY  - 1999///
VL  - 162
SP  - 2321
EP  - 2325
PB  - Nature Publishing Group
ER  -

TY  - JOUR
AU  - Gavrilyuk, V.
TI  - Identification of complement 5a-like receptor (C5L2) from astrocytes: characterization of anti-inflammatory properties
JA  - J. Neurochem.
PY  - 2005///
VL  - 92
SP  - 1140
EP  - 1149
PB  - Nature Publishing Group
M3  - 10.1111/j.1471-4159.2004.02942.x
N1  - 10.1111/j.1471-4159.2004.02942.x
UR  - http://dx.doi.org/10.1111/j.1471-4159.2004.02942.x
ER  -

TY  - JOUR
AU  - Wang, H.
TI  - HMG-1 as a late mediator of endotoxin lethality in mice
JA  - Science
PY  - 1999///
VL  - 285
SP  - 248
EP  - 251
PB  - Nature Publishing Group
M3  - 10.1126/science.285.5425.248
N1  - 10.1126/science.285.5425.248
UR  - http://dx.doi.org/10.1126/science.285.5425.248
ER  -

TY  - JOUR
AU  - Muller, S.
TI  - New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal
JA  - EMBO J.
PY  - 2001///
VL  - 20
SP  - 4337
EP  - 4340
PB  - Nature Publishing Group
M3  - 10.1093/emboj/20.16.4337
N1  - 10.1093/emboj/20.16.4337
UR  - http://dx.doi.org/10.1093/emboj/20.16.4337
ER  -

TY  - JOUR
AU  - Lotze, M.T.
AU  - Tracey, K.J.
TI  - High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
JA  - Nat. Rev. Immunol.
PY  - 2005///
VL  - 5
SP  - 331
EP  - 342
PB  - Nature Publishing Group
M3  - 10.1038/nri1594
N1  - 10.1038/nri1594
UR  - http://dx.doi.org/10.1038/nri1594
ER  -

TY  - JOUR
AU  - Suda, K.
TI  - Anti-high-mobility group box chromosomal protein 1 antibodies improve survival of rats with sepsis
JA  - World J. Surg.
PY  - 2006///
VL  - 30
SP  - 1755
EP  - 1762
PB  - Nature Publishing Group
M3  - 10.1007/s00268-005-0369-2
N1  - 10.1007/s00268-005-0369-2
UR  - http://dx.doi.org/10.1007/s00268-005-0369-2
ER  -

TY  - JOUR
AU  - Yang, H.
TI  - Reversing established sepsis with antagonists of endogenous high-mobility group box 1
JA  - Proc. Natl. Acad. Sci. USA
PY  - 2004///
VL  - 101
SP  - 296
EP  - 301
PB  - Nature Publishing Group
M3  - 10.1073/pnas.2434651100
N1  - 10.1073/pnas.2434651100
UR  - http://dx.doi.org/10.1073/pnas.2434651100
ER  -

TY  - JOUR
AU  - Qin, S.
TI  - Role of HMGB1 in apoptosis-mediated sepsis lethality
JA  - J. Exp. Med.
PY  - 2006///
VL  - 203
SP  - 1637
EP  - 1642
PB  - Nature Publishing Group
M3  - 10.1084/jem.20052203
N1  - 10.1084/jem.20052203
UR  - http://dx.doi.org/10.1084/jem.20052203
ER  -

TY  - JOUR
AU  - Hawlisch, H.
TI  - C5a negatively regulates Toll-like receptor 4-induced immune responses
JA  - Immunity
PY  - 2005///
VL  - 22
SP  - 415
EP  - 426
PB  - Nature Publishing Group
M3  - 10.1016/j.immuni.2005.02.006
N1  - 10.1016/j.immuni.2005.02.006
UR  - http://dx.doi.org/10.1016/j.immuni.2005.02.006
ER  -

TY  - JOUR
AU  - Zhang, X.
TI  - Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo
JA  - Blood
PY  - 2007///
VL  - 110
SP  - 228
EP  - 236
PB  - Nature Publishing Group
M3  - 10.1182/blood-2006-12-063636
N1  - 10.1182/blood-2006-12-063636
UR  - http://dx.doi.org/10.1182/blood-2006-12-063636
ER  -

TY  - JOUR
AU  - Koleva, M.
TI  - Induction of anaphylatoxin C5a receptors in rat hepatocytes by lipopolysaccharide in vivo: mediation by interleukin-6 from Kupffer cells
JA  - Gastroenterology
PY  - 2002///
VL  - 122
SP  - 697
EP  - 708
PB  - Nature Publishing Group
M3  - 10.1053/gast.2002.31883
N1  - 10.1053/gast.2002.31883
UR  - http://dx.doi.org/10.1053/gast.2002.31883
ER  -

TY  - JOUR
AU  - Kohl, J.
TI  - The role of complement in danger sensing and transmission
JA  - Immunol. Res.
PY  - 2006///
VL  - 34
SP  - 157
EP  - 176
PB  - Nature Publishing Group
M3  - 10.1385/IR:34:2:157
N1  - 10.1385/IR:34:2:157
UR  - http://dx.doi.org/10.1385/IR:34:2:157
ER  -

TY  - JOUR
AU  - Hawlisch, H.
AU  - Kohl, J.
TI  - Complement and Toll-like receptors: key regulators of adaptive immune responses
JA  - Mol. Immunol.
PY  - 2006///
VL  - 43
SP  - 13
EP  - 21
PB  - Nature Publishing Group
M3  - 10.1016/j.molimm.2005.06.028
N1  - 10.1016/j.molimm.2005.06.028
UR  - http://dx.doi.org/10.1016/j.molimm.2005.06.028
ER  -

TY  - JOUR
AU  - Kim, J.Y.
TI  - HMGB1 contributes to the development of acute lung injury after hemorrhage
JA  - Am. J. Physiol. Lung Cell. Mol. Physiol.
PY  - 2005///
VL  - 288
SP  - L958
EP  - L965
PB  - Nature Publishing Group
M3  - 10.1152/ajplung.00359.2004
N1  - 10.1152/ajplung.00359.2004
UR  - http://dx.doi.org/10.1152/ajplung.00359.2004
ER  -

TY  - JOUR
AU  - Wang, H.
TI  - Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
JA  - Nat. Med.
PY  - 2004///
VL  - 10
SP  - 1216
EP  - 1221
PB  - Nature Publishing Group
M3  - 10.1038/nm1124
N1  - 10.1038/nm1124
UR  - http://dx.doi.org/10.1038/nm1124
ER  -

TY  - JOUR
AU  - Bonaldi, T.
TI  - Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
JA  - EMBO J.
PY  - 2003///
VL  - 22
SP  - 5551
EP  - 5560
PB  - Nature Publishing Group
M3  - 10.1093/emboj/cdg516
N1  - 10.1093/emboj/cdg516
UR  - http://dx.doi.org/10.1093/emboj/cdg516
ER  -

TY  - JOUR
AU  - Godau, J.
TI  - C5a initiates the inflammatory cascade in immune complex peritonitis
JA  - J. Immunol.
PY  - 2004///
VL  - 173
SP  - 3437
EP  - 3445
PB  - Nature Publishing Group
ER  -

TY  - JOUR
AU  - Baelder, R.
TI  - Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation
JA  - J. Immunol.
PY  - 2005///
VL  - 174
SP  - 783
EP  - 789
PB  - Nature Publishing Group
ER  -

TY  - JOUR
AU  - Yamada, S.
AU  - Inoue, K.
AU  - Yakabe, K.
AU  - Imaizumi, H.
AU  - Maruyama, I.
TI  - High mobility group protein 1 (HMGB1) quantified by ELISA with a monoclonal antibody that does not cross-react with HMGB2
JA  - Clin. Chem.
PY  - 2003///
VL  - 49
SP  - 1535
EP  - 1537
PB  - Nature Publishing Group
M3  - 10.1373/49.9.1535
N1  - 10.1373/49.9.1535
UR  - http://dx.doi.org/10.1373/49.9.1535
ER  -
